Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Johnson

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2022
The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2Tim Vierbuchen, Shiuli Agarwal, John L Johnson, et al.
Plos One|October 8, 2013
Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in BrazilTeresa Gomes, Solange Alves Vinhas, Bárbara Reis-Santos, et al.
Journal of Clinical Microbiology|October 12, 2007
Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosisMoises Palaci, Reynaldo Dietze, David Jamil Hadad, et al.
Clinical and Diagnostic Laboratory Immunology|July 3, 2002
Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearanceRodrigo Ribeiro-Rodrigues, Tatiana Resende Co, John L Johnson, et al.
The Journal of Infection|May 11, 2024
Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosisHygon Mutavhatsindi, Charles M Manyelo, Candice I Snyders, et al.
Plos One|April 9, 2021
Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infectionBonnie A Thiel, William Worodria, Sophie Nalukwago, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2016
Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell ResponsesSara Suliman, Hennie Geldenhuys, John L Johnson, et al.
Plos One|December 11, 2013
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatmentMelissa R Nyendak, Byung Park, Megan D Null, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2009
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversionJohn L Johnson, David Jamil Hadad, Reynaldo Dietze, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2022
The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2Tim Vierbuchen, Shiuli Agarwal, John L Johnson, et al.
Plos One|October 8, 2013
Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in BrazilTeresa Gomes, Solange Alves Vinhas, Bárbara Reis-Santos, et al.
Journal of Clinical Microbiology|October 12, 2007
Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosisMoises Palaci, Reynaldo Dietze, David Jamil Hadad, et al.
Clinical and Diagnostic Laboratory Immunology|July 3, 2002
Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearanceRodrigo Ribeiro-Rodrigues, Tatiana Resende Co, John L Johnson, et al.
The Journal of Infection|May 11, 2024
Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosisHygon Mutavhatsindi, Charles M Manyelo, Candice I Snyders, et al.
Plos One|April 9, 2021
Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infectionBonnie A Thiel, William Worodria, Sophie Nalukwago, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2016
Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell ResponsesSara Suliman, Hennie Geldenhuys, John L Johnson, et al.
Plos One|December 11, 2013
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatmentMelissa R Nyendak, Byung Park, Megan D Null, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2009
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversionJohn L Johnson, David Jamil Hadad, Reynaldo Dietze, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
Pageof 11